Opthea Limited (OPT) announced executive leadership changes in Commercial and Finance as well as senior hires for Biometrics, Clinical Operations and Market Access. Daniel Geffken, Co-Founder and Managing Director, Danforth Advisors, will assume the role of Chief Financial Officer on an ad interim basis. Daniel Geffken succeeds Peter Lang.
Mike Campbell has been appointed Chief Commercial Officer. Campbell has 30 years of biotech and pharmaceutical commercial leadership experience. Mike Campbell succeeds Judith Robertson.
The company announced the appointment of Dayong Li as Senior Vice President, Biometrics. He most recently served as Senior Vice President, Biometrics, at Marinus Pharmaceuticals. Jen Watts has been appointed Vice President Global Clinical Operations. Anthony Bonifazio has been appointed Vice President, Market Access. Bonifazio joins Opthea from Astellas.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.